Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ALGN Align Technology	$159.71 -3.0%	$205.41	$158.36 ▼ $335.40	$11.75B	1.69	780,487 shs	691,221 shs
GEHC GE HealthCare Technologies	$81.33 -2.9%	$87.17	$74.51 ▼ $94.80	$37.19B	1.13	2.99 million shs	1.57 million shs
ISRG Intuitive Surgical	$475.59 -4.4%	$569.42	$364.17 ▼ $616.00	$169.61B	1.43	1.43 million shs	1.99 million shs
SWAV Shockwave Medical	$334.75	$332.85	$157.00 ▼ $334.90	$12.57B	0.88	968,088 shs	N/A
ZBH Zimmer Biomet	$106.10 +2.0%	$105.65	$97.69 ▼ $133.90	$21.12B	1.04	1.89 million shs	697,283 shs

(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ALGN Align Technology	-0.35%	-5.52%	-22.38%	-30.18%	-47.03%
GEHC GE HealthCare Technologies	-2.10%	-1.14%	-4.24%	+2.65%	-8.75%
ISRG Intuitive Surgical	+0.73%	-12.45%	-16.52%	-8.71%	+27.71%
SWAV Shockwave Medical	0.00%	0.00%	0.00%	0.00%	+26.46%
ZBH Zimmer Biomet	-3.04%	-0.58%	+3.69%	-2.56%	-18.80%

Remove Ads

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ALGN Align Technology	4.3581 of 5 stars	4.4	1.0	0.0	3.8	2.6	1.7	1.3
GEHC GE HealthCare Technologies	3.3364 of 5 stars	2.4	3.0	1.7	0.0	3.1	1.7	2.5
ISRG Intuitive Surgical	4.8216 of 5 stars	4.4	3.0	0.0	4.0	3.0	2.5	1.9
SWAV Shockwave Medical	1.2647 of 5 stars	1.1	0.0	0.0	4.6	0.6	1.7	1.9
ZBH Zimmer Biomet	4.6185 of 5 stars	3.2	4.0	1.7	3.7	3.1	2.5	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ALGN Align Technology	2.77	Moderate Buy	$269.91	69.00% Upside
GEHC GE HealthCare Technologies	2.77	Moderate Buy	$98.75	21.43% Upside
ISRG Intuitive Surgical	2.71	Moderate Buy	$613.10	28.91% Upside
SWAV Shockwave Medical	2.11	Hold	$344.67	2.96% Upside
ZBH Zimmer Biomet	2.32	Hold	$124.15	17.01% Upside

Current Analyst Ratings Breakdown

Latest SWAV, GEHC, ISRG, ALGN, and ZBH Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
3/11/2025	GEHC GE HealthCare Technologies	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$85.00 ➝ $100.00
2/14/2025	ALGN Align Technology	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$255.00
2/14/2025	GEHC GE HealthCare Technologies	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$96.00 ➝ $103.00
2/13/2025	GEHC GE HealthCare Technologies	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$103.00 ➝ $110.00
2/10/2025	ZBH Zimmer Biomet	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold	$118.00 ➝ $113.00
2/10/2025	ZBH Zimmer Biomet	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Underweight ➝ Underweight	$118.00 ➝ $112.00
2/7/2025	ZBH Zimmer Biomet	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$130.00 ➝ $125.00
2/7/2025	ZBH Zimmer Biomet	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Outperform ➝ Market Outperform	$140.00 ➝ $140.00
2/7/2025	ZBH Zimmer Biomet	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$126.00 ➝ $119.00
2/7/2025	ZBH Zimmer Biomet	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold
2/6/2025	ALGN Align Technology	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$240.00 ➝ $260.00

(Data available from 3/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ALGN Align Technology	$4.00B	2.94	$8.29 per share	19.26	$51.60 per share	3.10
GEHC GE HealthCare Technologies	$19.67B	1.89	$5.10 per share	15.94	$18.51 per share	4.39
ISRG Intuitive Surgical	$8.35B	20.28	$6.26 per share	75.93	$46.41 per share	10.25
SWAV Shockwave Medical	$787.97M	15.95	$4.31 per share	77.61	$20.02 per share	16.72
ZBH Zimmer Biomet	$7.68B	2.75	$13.52 per share	7.85	$62.67 per share	1.69

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ALGN Align Technology	$421.36M	$5.61	28.46	17.84	2.24	10.54%	13.84%	8.51%	4/30/2025 (Estimated)
GEHC GE HealthCare Technologies	$1.99B	$4.33	18.78	15.64	3.19	10.13%	25.74%	6.29%	4/29/2025 (Estimated)
ISRG Intuitive Surgical	$2.32B	$6.41	74.29	62.33	5.85	27.81%	14.55%	12.88%	4/17/2025 (Estimated)
SWAV Shockwave Medical	$147.28M	$4.28	78.21	54.34	2.43	20.75%	24.79%	11.95%	N/A
ZBH Zimmer Biomet	$903.70M	$4.45	23.85	11.96	1.95	11.77%	12.99%	7.58%	5/1/2025 (Estimated)

Latest SWAV, GEHC, ISRG, ALGN, and ZBH Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
2/13/2025	Q4 2024	GEHC GE HealthCare Technologies	$1.26	$1.45	+$0.19	$1.57	$5.33 billion	$5.32 billion
2/6/2025	Q4 24	ZBH Zimmer Biomet	$2.30	$2.31	+$0.01	$1.20	$2.01 billion	N/A
2/5/2025	Q4 2024	ALGN Align Technology	$2.43	$1.96	-$0.47	$1.39	$999.16 million	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ALGN Align Technology	N/A	N/A	N/A	N/A	N/A
GEHC GE HealthCare Technologies	$0.14	0.17%	N/A	3.23%	N/A
ISRG Intuitive Surgical	N/A	N/A	N/A	N/A	N/A
SWAV Shockwave Medical	N/A	N/A	N/A	N/A	N/A
ZBH Zimmer Biomet	$0.96	0.90%	N/A	21.57%	N/A

Latest SWAV, GEHC, ISRG, ALGN, and ZBH Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/26/2025	ZBH Zimmer Biomet	quarterly	$0.24	0.89%	3/31/2025	3/31/2025	4/30/2025
12/18/2024	ZBH Zimmer Biomet	quarterly	$0.24	0.89%	12/30/2024	12/30/2024	1/31/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ALGN Align Technology	N/A	1.22	1.10
GEHC GE HealthCare Technologies	0.88	1.04	0.83
ISRG Intuitive Surgical	N/A	4.07	3.22
SWAV Shockwave Medical	0.97	13.81	12.61
ZBH Zimmer Biomet	0.43	1.91	0.99

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ALGN Align Technology	88.43%
GEHC GE HealthCare Technologies	82.06%
ISRG Intuitive Surgical	83.64%
SWAV Shockwave Medical	95.35%
ZBH Zimmer Biomet	88.89%

Insider Ownership

Company	Insider Ownership
ALGN Align Technology	0.62%
GEHC GE HealthCare Technologies	0.27%
ISRG Intuitive Surgical	0.90%
SWAV Shockwave Medical	3.40%
ZBH Zimmer Biomet	0.95%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ALGN Align Technology	21,610	73.60 million	74.19 million	Optionable
GEHC GE HealthCare Technologies	50,000	457.30 million	456.06 million	Optionable
ISRG Intuitive Surgical	15,638	356.18 million	352.97 million	Optionable
SWAV Shockwave Medical	1,468	37.54 million	36.27 million	Optionable
ZBH Zimmer Biomet	18,000	199.06 million	197.18 million	Optionable

SWAV, GEHC, ISRG, ALGN, and ZBH Headlines

Recent News About These Companies

Edgestream Partners L.P. Has $632,000 Stock Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

March 13 at 3:47 AM | marketbeat.com

Assetmark Inc. Trims Stock Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

March 13 at 3:30 AM | marketbeat.com

Q3 EPS Estimates for Zimmer Biomet Reduced by Zacks Research

March 13 at 2:04 AM | americanbankingnews.com

Zacks Research Expects Weaker Earnings for Zimmer Biomet

March 13 at 1:11 AM | americanbankingnews.com

ZBH Stock to Gain From Global Expansion Amid Difficult FX Scenario

March 12 at 1:20 PM | zacks.com

Q1 EPS Estimates for Zimmer Biomet Lowered by Zacks Research

March 12 at 7:53 AM | marketbeat.com

Q3 EPS Estimates for Zimmer Biomet Cut by Zacks Research

March 12 at 7:25 AM | marketbeat.com

Paragon 28 announces expiration of HSR waiting period for pending acquisition

March 11 at 4:53 PM | markets.businessinsider.com

Amundi Sells 71,482 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

March 11 at 4:29 AM | marketbeat.com

PNC Financial Services Group Inc. Reduces Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

March 11 at 4:21 AM | marketbeat.com

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Stock Holdings Lowered by Steward Partners Investment Advisory LLC

March 11 at 3:35 AM | marketbeat.com

Zimmer Biomet launches Tekcem 1G and Tekcem 3G antibiotic bone cements in India

March 11 at 1:39 AM | expresshealthcare.in

Arnold Schwarzenegger flexes joint awareness in Zimmer Biomet campaign

March 10 at 3:38 PM | mmm-online.com

Zimmer Biomet Highlights Diverse Portfolio of Orthopedic & Musculoskeletal Innovations at AAOS 2025 Annual Meeting

March 10 at 7:30 AM | prnewswire.com

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Sold by Johnson Investment Counsel Inc.

March 10 at 6:47 AM | marketbeat.com

Mesirow Financial Investment Management Inc. Sells 2,749 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

March 10 at 4:41 AM | marketbeat.com

Ashton Thomas Private Wealth LLC Boosts Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

March 10 at 4:33 AM | marketbeat.com

Candriam S.C.A. Has $2.30 Million Stock Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

March 10 at 4:24 AM | marketbeat.com

River Global Investors LLP Cuts Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

March 9, 2025 | marketbeat.com

Generali Investments CEE investicni spolecnost a.s. Acquires Shares of 6,100 Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

March 9, 2025 | marketbeat.com

10,911 Shares in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Purchased by Callan Family Office LLC

March 9, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

SWAV, GEHC, ISRG, ALGN, and ZBH Company Descriptions

Align Technology NASDAQ:ALGN

$159.71 -4.86 (-2.95%)

As of 01:57 PM Eastern

Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth. The segment also provides Invisalign moderate, lite and express packages, and Invisalign go and Invisalign Go Plus; retention products, Invisalign training, and adjusting tools used by dental professionals during the course of treatment; and Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and orthodontists software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers. This segment also provides Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface designed to enhance dental consultations; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan, as well as subscription software, disposables, rentals, leases, pay per scan, and CAD/CAM software solutions. The company was incorporated in 1997 and is headquartered in Tempe, Arizona.

GE HealthCare Technologies NASDAQ:GEHC

$81.32 -2.47 (-2.94%)

As of 01:57 PM Eastern

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

Intuitive Surgical NASDAQ:ISRG

$475.59 -21.71 (-4.37%)

As of 01:57 PM Eastern

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Shockwave Medical NASDAQ:SWAV

Shockwave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system; and Reducer, a device to treat refractory angina. In addition, the company develops COSIRA-II trial; shockwave C2 Aero, a coronary IVL catheter; shockwave javelin coronary, a non-balloon-based catheter platform to treat of tight, difficult-to-cross coronary lesions; shockwave L6; shockwave E8 catheter, to target long peripheral artery lesions; shockwave javelin peripheral, a non-balloon-based catheter platform, to treat tight, difficult-to-cross peripheral lesions. Further, it offers shockwave carotid IVL, a purpose-built IVL System to treat calcified carotid artery lesions; and Shockwave Crescendo, a platform developed to treat calcified, stenotic heart valves. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.

Zimmer Biomet NYSE:ZBH

$106.10 +2.07 (+1.99%)

As of 01:57 PM Eastern

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time